Medicare Part D Premium Hikes May Push Seniors to Medicare Advantage

The Trump administration's decision to terminate a federal program that helped keep Medicare prescription drug plan costs in check is poised to reshape how millions of seniors choose their coverage, with Medicare Advantage plans emerging as the likely beneficiaries of the fallout.

With Medicare Part D standalone drug plan premiums expected to climb as a result of the policy change, beneficiaries facing higher out-of-pocket costs may find bundled Medicare Advantage plans — which typically fold prescription drug coverage into a single package — a more financially attractive alternative. The shift could accelerate an already notable trend of seniors migrating away from traditional fee-for-service Medicare.

Read more Trump Defends Tariffs After Supreme Court Ruling, Eyes 2026 Midterms →

The decision underscores the broader tension in federal health policy between controlling program costs and maintaining affordable coverage options for older Americans. Critics of the move argue that eliminating the subsidy mechanism prematurely removes a meaningful safeguard that kept standalone Part D plans competitive and accessible, particularly for lower-income enrollees who rely heavily on drug coverage.

For insurers that dominate the Medicare Advantage market, the development could translate into enrollment gains during the next open enrollment period, as plan-shopping seniors weigh rising Part D premiums against the all-in pricing structures that Advantage plans offer. Analysts caution, however, that Medicare Advantage plans carry their own trade-offs, including network restrictions and prior authorization requirements that can limit access to care.

The downstream effects on federal spending, insurer profitability, and beneficiary health outcomes remain to be seen, but the early end to this cost-control program marks a significant pivot in how the administration is approaching Medicare's financial architecture. Continue reading at MarketWatch.com